• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性心房颤动的流行病学特征:弗雷明汉姆研究

Epidemiologic features of chronic atrial fibrillation: the Framingham study.

作者信息

Kannel W B, Abbott R D, Savage D D, McNamara P M

出版信息

N Engl J Med. 1982 Apr 29;306(17):1018-22. doi: 10.1056/NEJM198204293061703.

DOI:10.1056/NEJM198204293061703
PMID:7062992
Abstract

In the Framingham Study 2325 men and 2866 women 30 to 62 years old at entry were followed biennially over 22 years for the development of chronic atrial fibrillation in relation to antecedent cardiovascular disease and risk factors. During surveillance, atrial fibrillation developed in 49 men and 49 women. The incidence rose sharply with age but did not differ significantly between the sexes. Overall, there was a 2.0 per cent chance that the disorder would develop in two decades. Atrial fibrillation usually followed the development of overt cardiovascular disease. Only 18 men and 12 women (31 per cent) had chronic atrial fibrillation in the absence of cardiovascular disease. Cardiac failure and rheumatic heart disease were the most powerful predictive precursors, with relative risks in excess of sixfold. Hypertensive cardiovascular disease was the most common antecedent disease, largely because of its frequency in the general population. Among the risk factors for cardiovascular disease, diabetes and electrocardiographic evidence of left ventricular hypertrophy were related to the occurrence of atrial fibrillation. The development of chronic atrial fibrillation was associated with a doubling of overall mortality and of mortality from cardiovascular disease.

摘要

在弗明汉姆研究中,对入组时年龄在30至62岁的2325名男性和2866名女性进行了为期22年的随访,每两年进行一次,以观察慢性房颤的发生与既往心血管疾病及危险因素之间的关系。在监测期间,49名男性和49名女性发生了房颤。发病率随年龄急剧上升,但两性之间无显著差异。总体而言,在二十年内发生这种疾病的几率为2.0%。房颤通常在明显的心血管疾病发生之后出现。只有18名男性和12名女性(31%)在无心血管疾病的情况下患有慢性房颤。心力衰竭和风湿性心脏病是最有力的预测先兆,相对风险超过六倍。高血压性心血管疾病是最常见的既往疾病,主要是因为其在普通人群中的发病率较高。在心血管疾病的危险因素中,糖尿病和左心室肥厚的心电图证据与房颤的发生有关。慢性房颤的发生与总死亡率和心血管疾病死亡率的加倍有关。

相似文献

1
Epidemiologic features of chronic atrial fibrillation: the Framingham study.慢性心房颤动的流行病学特征:弗雷明汉姆研究
N Engl J Med. 1982 Apr 29;306(17):1018-22. doi: 10.1056/NEJM198204293061703.
2
Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study.基于人群队列的房颤独立危险因素。弗明汉心脏研究。
JAMA. 1994 Mar 16;271(11):840-4.
3
Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates.心房颤动的患病率、发病率、预后及诱发因素:基于人群的估计
Am J Cardiol. 1998 Oct 16;82(8A):2N-9N. doi: 10.1016/s0002-9149(98)00583-9.
4
Lifetime risk for development of atrial fibrillation: the Framingham Heart Study.心房颤动发生的终生风险:弗雷明汉心脏研究
Circulation. 2004 Aug 31;110(9):1042-6. doi: 10.1161/01.CIR.0000140263.20897.42. Epub 2004 Aug 16.
5
Atrial fibrillation revisited.心房颤动再探讨。
N Engl J Med. 1982 Apr 29;306(17):1044-5. doi: 10.1056/NEJM198204293061709.
6
Impact of atrial fibrillation on the risk of death: the Framingham Heart Study.心房颤动对死亡风险的影响:弗雷明汉心脏研究
Circulation. 1998 Sep 8;98(10):946-52. doi: 10.1161/01.cir.98.10.946.
7
[Atrial fibrillation: prevalence, risk factors and mortality in a large French population with 15 years of follow-up].[心房颤动:法国一大规模人群15年随访中的患病率、危险因素及死亡率]
Bull Acad Natl Med. 2007 Apr-May;191(4-5):791-803; discussion 803-5.
8
Comparison of probability of stroke between the Copenhagen City Heart Study and the Framingham Study.哥本哈根市心脏研究与弗雷明汉心脏研究中中风概率的比较。
Stroke. 1994 Apr;25(4):802-7. doi: 10.1161/01.str.25.4.802.
9
Hospitalizations for atrial fibrillation in the general male population: morbidity and risk factors.普通男性人群中心房颤动的住院治疗:发病率及危险因素。
J Intern Med. 2001 Nov;250(5):382-9. doi: 10.1046/j.1365-2796.2001.00902.x.
10
[Impact of chronic atrial fibrillation on cardiovacular mortality].[慢性心房颤动对心血管死亡率的影响]
Ital Heart J Suppl. 2000 Sep;1(9):1117-22.

引用本文的文献

1
Assessing the risk factors of permanent pacemaker implantation following mitral valve surgery: A systematic review and meta-analysis.评估二尖瓣手术后永久性起搏器植入的危险因素:一项系统评价和荟萃分析。
Medicine (Baltimore). 2025 Sep 5;104(36):e44232. doi: 10.1097/MD.0000000000044232.
2
Diabetes and Obesity and Treatment Effect of Early Rhythm Control vs Usual Care in Patients With Atrial Fibrillation: A Secondary Analysis of the EAST-AFNET 4 Randomized Clinical Trial.糖尿病与肥胖以及早期节律控制与常规治疗对心房颤动患者的治疗效果:EAST-AFNET 4随机临床试验的二次分析
JAMA Cardiol. 2025 Jul 30. doi: 10.1001/jamacardio.2025.2374.
3
Antiarrhythmic drug use in atrial fibrillation among different European countries - as determined by a physician survey.
不同欧洲国家心房颤动患者抗心律失常药物的使用情况——基于一项医师调查的结果
Int J Cardiol Heart Vasc. 2025 May 31;59:101709. doi: 10.1016/j.ijcha.2025.101709. eCollection 2025 Aug.
4
Atrial fibrillation in the Americas.美洲地区的心房颤动。
Lancet Reg Health Am. 2025 May 6;47:101110. doi: 10.1016/j.lana.2025.101110. eCollection 2025 Jul.
5
Safety of His-bundle ablation after pacemaker implantation in patients with persistent or permanent atrial fibrillation.起搏器植入术后持续性或永久性心房颤动患者希氏束消融的安全性
Herzschrittmacherther Elektrophysiol. 2025 Jun;36(2):132-137. doi: 10.1007/s00399-025-01082-w. Epub 2025 Jun 5.
6
Triple cardiovascular disease detection with an artificial intelligence-enabled stethoscope (TRICORDER): design and rationale for a decentralised, real-world cluster-randomised controlled trial and implementation study.使用人工智能听诊器进行心血管疾病三联检测(TRICORDER):一项去中心化、真实世界整群随机对照试验及实施研究的设计与原理
BMJ Open. 2025 May 21;15(5):e098030. doi: 10.1136/bmjopen-2024-098030.
7
Description of Atrial Fibrillation in a Cardiology Department in Mahajanga, Madagascar.马达加斯加马任加某心脏病科心房颤动的描述
Cureus. 2025 Apr 15;17(4):e82282. doi: 10.7759/cureus.82282. eCollection 2025 Apr.
8
The Impact of Weight Categories on the Association Between Atrial Fibrillation/Flutter and Known Risk Factors: A Nationwide Inpatient Data Analysis.体重类别对心房颤动/扑动与已知危险因素之间关联的影响:一项全国住院患者数据分析。
J Clin Med. 2025 Mar 23;14(7):2187. doi: 10.3390/jcm14072187.
9
Mitigation of atrial fibrillation-related complications with antithrombotic and cytoreductive therapy in patients with Myeloproliferative Neoplasms: Implications from the GSG-MPN bioregistry.骨髓增殖性肿瘤患者应用抗栓和细胞减灭治疗减轻心房颤动相关并发症:来自GSG-MPN生物注册研究的启示
Hemasphere. 2025 Mar 17;9(3):e70090. doi: 10.1002/hem3.70090. eCollection 2025 Mar.
10
Outcomes and Disease Management in Patients With Atrial Fibrillation ≥80 Years: Data From a Consecutive 11-Year Real-World Registry.80岁及以上心房颤动患者的结局与疾病管理:来自连续11年真实世界注册研究的数据
J Am Heart Assoc. 2025 Feb 18;14(4):e036832. doi: 10.1161/JAHA.124.036832. Epub 2025 Feb 8.